Natasa Djordjevic, MD, PhD, has completed a MD (2000) and a MSc in Clinical and Experimental Pharmacology (2003) at the University of Kragujevac, Serbia, with MD subsequently validated at the Medical Faculty University of Ljubljana, Slovenia (2004). She earned a PhD in Clinical and Experimental Pharmacology from the University of Kragujevac (2008) and a PhD in Clinical Pharmacology – Pharmacogenetics from the Karolinska Institute (2012), as well as completed a PA in Clinical Pharmacology at the University of Kragujevac in 2013. She currently works as a Full Professor at the Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. Her scientific contribution is focused mostly on pharmacogenetics and pharmacogenomics, with an aim to assist the ongoing efforts of their integration into clinical decision-making and public health strategies. Her published work concentrates on advancing the understanding of genetic factors influencing drug disposition, optimizing laboratory methodologies for genetic analysis, encouraging the application of genomic data in public health, and translating genomic findings into practical healthcare solutions. Her publications underscore the potential of pharmacogenetics to revolutionize healthcare by fostering personalized medicine. She is a member of Swedish Institute Alumni Network, Karolinska Institute Alumni Network, as well as Fulbright Alumni Association of Serbia.